Shandong Jincheng Pharmaceutical Group Co., Ltd Share Price
Equities
300233
CNE100001500
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.51 CNY | +1.85% | +8.62% | -0.90% |
Sales 2022 | 3.51B 484M 40.33B | Sales 2023 | 3.54B 488M 40.7B | Capitalization | 6.34B 874M 72.89B |
---|---|---|---|---|---|
Net income 2022 | 273M 37.68M 3.14B | Net income 2023 | 175M 24.15M 2.01B | EV / Sales 2022 | 2.43 x |
Net cash position 2022 | 208M 28.74M 2.4B | Net cash position 2023 | 471M 64.94M 5.41B | EV / Sales 2023 | 1.66 x |
P/E ratio 2022 |
32.1
x | P/E ratio 2023 |
37
x | Employees | 3,806 |
Yield 2022 |
0.66% | Yield 2023 |
1.2% | Free-Float | 29.66% |
1 day | +1.85% | ||
1 week | +8.62% | ||
Current month | +7.28% | ||
1 month | +4.23% | ||
3 months | +15.21% | ||
6 months | -6.46% | ||
Current year | -0.90% |
Managers | Title | Age | Since |
---|---|---|---|
Jia Quan Li
PSD | President | 52 | 01/08/01 |
Jing Liu
DFI | Director of Finance/CFO | 48 | - |
Geng Xiu Zheng
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/04/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ye Qing Zhao
CHM | Chairman | 47 | 01/04/01 |
Jia Quan Li
PSD | President | 52 | 01/08/01 |
Geng Xiu Zheng
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/04/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 16.51 | +1.85% | 5,568,190 |
25/24/25 | 16.21 | +3.78% | 6,766,101 |
24/24/24 | 15.62 | +1.03% | 3,144,800 |
23/24/23 | 15.46 | +1.18% | 3,776,105 |
22/24/22 | 15.28 | +0.53% | 3,515,601 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.90% | 875M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300233 Stock